Edge is where we experiment with new ideas and features before bringing them to Jupiter. Let us know what you think!
Rewards

ABBVIE INC. (ABBV)

Underlying price

$289.65

+0.49% today

Stock stats

Market cap
$514B
Previous close
$288.24
Open
$282.27
Day's range
$281.79 – $291.64
52-week range
$190.75 – $302.93
Volume
3.44M
Avg volume
4.81M
P/E ratio
49.53
EPS
$5.82
Dividend yield
2.38%
Beta
0.185
Next earnings
-

About ABBVIE INC.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.

Ticker
ABBV
Asset class
Equity
Tokenized by
1 issuer
Sector
Healthcare
Industry
Pharmaceutical Preparations
Employees
57,000
Website
abbvie.com

ABBVIE INC. FAQ

ABBV is ABBVIE INC. stock, issued on Solana as a token that tracks the listed share. Each issuer mints its own version, so ABBVIE INC. trades here as one token.